Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Cancer
Interventions: BIOLOGICAL: aldesleukin|BIOLOGICAL: therapeutic tumor infiltrating lymphocytes|BIOLOGICAL: trastuzumab|DRUG: paclitaxel|PROCEDURE: conventional surgery
Sponsor: National Cancer Institute (NCI)